NCT04038619
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +50 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Nevi and Melanomas
Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.
2,399 public trials
410 recruiting studies
Nevi and Melanomas trial results
NCT06398418
- Conditions
- Adenoma, Basal Cell Cancer, Melanoma, +17 more
- Locations
-
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research Institute Denver, Colorado, United States
NCT04752826
- Conditions
- Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
- Rigshospitalet Copenhagen, Denmark
NCT05267626
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
- Locations
-
- Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
- START Midwest Grand Rapids, Michigan, United States
- Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States
- Washington University St Louis, Missouri, United States
Recruiting
Genetic Basis of Melanocytic Nevi
NCT03054584
- Conditions
- Melanocytic Nevi, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- University of California-Davis, Department of Dermatology Sacramento, California, United States
NCT05155033
- Conditions
- Adenocarcinoma, Advanced Locoregional Melanoma, Carcinoma, +26 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07492680
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +22 more
- Locations
-
- Local Institution - 0096 San Francisco, California, United States
- Local Institution - 0182 Aurora, Colorado, United States
- Local Institution - 0124 Boston, Massachusetts, United States
- Local Institution - 0119 Ann Arbor, Michigan, United States
Recruiting
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
NCT04741997
- Conditions
- BRAF V600 Mutation, Melanoma, Melanoma Stage III, +12 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT06623461
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- BCCA - Abbotsford Abbotsford British Columbia, British Columbia, Canada
- BCCA - Surrey Surrey, British Columbia, Canada
- BCCA - Vancouver Vancouver, British Columbia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
NCT05607095
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +16 more
- Locations
-
- Memorial Sloan Kettering Westchester Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States